ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,8,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
7,2,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
8,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
8,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
10,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
12,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
13,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
14,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
14,2,Blood arsenic increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
14,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,4,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
14,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
15,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
16,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
16,2,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
16,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
17,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
18,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
19,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
20,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
20,3,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
20,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
20,5,Headache,Headaches NEC,Headaches,Nerv,N
20,6,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
20,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
20,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
20,9,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
20,10,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
21,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
21,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
21,3,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
22,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
22,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
22,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
22,4,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
23,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
23,2,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
23,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
23,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
24,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
25,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
26,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
